Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATShares Issued
Ratios

Forte Biosciences (FBRX) Accumulated Depreciation & Amortization (2016 - 2019)

Forte Biosciences (FBRX) has disclosed Accumulated Depreciation & Amortization for 4 consecutive years, with $3.1 million as the latest value for Q4 2019.

  • Quarterly Accumulated Depreciation & Amortization fell 5.85% to $3.1 million in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $3.1 million through Dec 2019, down 5.85% year-over-year, with the annual reading at $3.1 million for FY2019, 5.85% down from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2019 was $3.1 million at Forte Biosciences, down from $3.3 million in the prior quarter.
  • The five-year high for Accumulated Depreciation & Amortization was $3.3 million in Q4 2018, with the low at $2.4 million in Q4 2016.
  • Average Accumulated Depreciation & Amortization over 4 years is $2.9 million, with a median of $2.9 million recorded in 2017.
  • The sharpest move saw Accumulated Depreciation & Amortization grew 23.1% in 2018, then dropped 5.85% in 2019.
  • Over 4 years, Accumulated Depreciation & Amortization stood at $2.4 million in 2016, then grew by 12.1% to $2.7 million in 2017, then increased by 23.1% to $3.3 million in 2018, then decreased by 5.85% to $3.1 million in 2019.
  • According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods came in at $3.1 million, $3.3 million, and $2.7 million for Q4 2019, Q4 2018, and Q4 2017 respectively.